NCT03159611 - Efficacy and Safety Clinical Trial of Tenoten for Children Liquid Dosage Form Therapy in Infants With Sequelae of Perinatal Brain Injury | Biotech Hunter

Enrollment

182

Participants

Timeline

Start Date

February 19, 2016

Primary Completion Date

February 9, 2018

Study Completion Date

February 9, 2018

Conditions

Sequelae of Perinatal Brain Injury

Interventions

DRUG

Tenoten for children

Oral. 10 drops daily, at the same time in the morning, 15 minutes before feeding.

DRUG

Placebo

Oral. 10 drops daily, at the same time in the morning, 15 minutes before feeding.

Trial Locations (10)

117997

Pirogov Russian National Research Medical University, Moscow

119991

I.M. Sechenov First MSMU, Moscow

129110

"Moscow Regional Research and Clinical Institute (MONIKI)", Moscow

150000

"Federal State Budgetary Educational Institutionof Higher Education Yaroslavl State Medical University of the Ministry of Healthcare of the Russian Federation", Yaroslavl

410005

"LLC Center for DNA Research", Saratov

420012

"Federal State Budgetary Educational Institution of Higher Education Kazan Medical University of the Ministry of Healthcare of the Russian Federation", Kazan'

443079

"State budgetary institution of public health of the Samara region Samara City Children's Clinical Hospital No. 1 named after N.N. Ivanova", Samara

614066

"Municipal Health Care Institution City Child Health Clinical Polyclinic №5", Perm

620149

"State Budgetary Healthcare Institution of Sverdlovsk Region Children's Clinical Hospital of Rehabilitation The Scientific and Practical Center Bonum", Yekaterinburg

634034

LLC Nebbiolo, Tomsk